List of works - Makoto Emori

Autologous CTL response against cancer stem-like cells/cancer-initiating cells of bone malignant fibrous histiocytoma

scientific article published on 31 May 2011

Development of next-generation peptide vaccination therapy

scientific article published on 01 February 2017

Differential diagnosis of fibroma of tendon sheath and giant cell tumor of tendon sheath in the finger using signal intensity on T2 magnetic resonance imaging

scientific article published on 07 December 2020

Early Lymph Node Metastasis May Predict Poor Prognosis in Soft Tissue Sarcoma

scientific article published on 12 December 2019

Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity

scientific article

Glossopharyngeal and Hypoglossal Nerve Paralysis Secondary to Prevertebral Phlegmon

scientific article published on 11 February 2020

High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma

scientific article published in 2013

Identification of a novel human memory T-cell population with the characteristics of stem-like chemo-resistance

scientific article published on 8 June 2016

Implication of chemo-resistant memory T cells for immune surveillance in patients with sarcoma receiving chemotherapy.

scientific article published on 12 July 2017

Osteofibrous dysplasia-like adamantinoma treated via intercalary segmental resection with partial cortex preservation using pedicled vascularized fibula graft: a case report

scientific article published on 13 August 2020

Osteosarcoma-initiating cells show high aerobic glycolysis and attenuation of oxidative phosphorylation mediated by LIN28B

scientific article published on 29 November 2019

Prognostic impact of CD109 expression in myxofibrosarcoma

scientific article published on 28 May 2015

SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group

scientific article published on 07 August 2012

Specific targeting of a naturally presented osteosarcoma antigen, papillomavirus binding factor peptide, using an artificial monoclonal antibody